Blog
How simpler implementations enable complex cell and gene therapies
After spending 12 years working in the biopharmaceutical industry – three of those here at Vineti – I’ve learned first-hand that cell and gene therapies (CGTs) present a unique environment for software implementation.st
Vineti joins the leadership of the Standards Coordinating Body
At Vineti, we’re pushing every day to help the field of advanced therapies — cell therapy, gene therapy, personalized cancer...
Cell therapy standards in action — a new case study on labeling
In cell therapy and gene therapy, in-process and final product labeling matters more to patient safety than ever before —...
ISCT 2019: data elements in the cell therapy value chain
I just got back from speaking at the International Society for Cell Therapy annual meeting, where the topic was next-gen data management....
Supply chain management readiness, Part 3: process
(Note: this post is the third part of a four-part series on supply chain planning for personalized therapies such as...
Cell therapy and gene therapy versus cancer: 10 numbers to watch
ASCO 2019 is here! In 2018, ASCO named CAR-T cell therapy the cancer Advance of the Year, and this year’s ASCO brings more cell...
When the patient is the product — some key challenges in cell and gene therapies
In personalized therapies — cell therapies, gene therapies, and neoantigen therapies — a patient is not just the recipient of...
Cell and gene therapy standards need you!
One week to go! In the next seven days, those of us working in cell and gene therapy have a...
Supply chain management readiness, Part 2: operational ecosystem
(Note: this post is the second part of a four-part series on supply chain planning for personalized therapies such as...
Cell and gene therapy news: some recent highlights
Things keep moving fast in the world of cell and gene therapy. Here are a few of the recent developments...
Commercial lessons for clinical-phase success, Part I: it all starts with collaboration
In early-phase clinical research, it’s common to think that your science resides within your lab. But when it comes to...
Q1 update from Vineti
As 2019 shapes up to be yet another landmark year for advanced therapies, Vineti is hard at work on our...
Supply chain management readiness, Part 1: strategy
There are many critical decisions to be made when moving a large-molecule biologic out of the lab into human trials....